Predictors of Trichomonas vaginalis infection among HIV-infected women receiving gynaecological care at a large university HIV clinic in Alabama
| Variable | Unadjusted OR (95% CI) | p Value* | Adjusted OR (95% CI) | p Value* |
|---|---|---|---|---|
| Age (n=469) | 0.95 (0.93 to 0.98) | 0.01 | 0.95 (0.92 to 0.99) | 0.01 |
| Race (n=478) | ||||
| African-American | 2.2 (1.2 to 4.1) | 0.01 | 3.0 (1.3 to 7.1) | 0.01 |
| White | Reference | Reference | ||
| Ever smoked (n=440) | ||||
| Yes | 1.7 (1.1 to 2.9) | 0.02 | 1.8 (0.7 to 3.7) | 0.13 |
| No | Reference | Reference | ||
| Alcohol abuse, ever (n=327) | ||||
| Yes | 1.1 (0.6 to 2.2) | 0.70 | − | |
| No | Reference | |||
| Illegal drug use, ever (n=345) | ||||
| Yes | 1.8 (1.0 to 3.0) | 0.03 | 1.5 (0.7 to 3.2) | 0.25 |
| No | Reference | Reference | ||
| HAART therapy at time of visit (n=464) | ||||
| Yes | 0.5 (0.3 to 0.8) | 0.01 | 1.0 (0.4 to 2.1) | 0.99 |
| No | Reference | Reference | ||
| Absolute CD4 count within 3 months of visit (n=433) | ||||
| <200 cells/mm3 | 1.2 (0.6 to 2.3) | 0.52 | − | |
| ≥200 cells/mm3 | Reference | |||
| HIV viral load within 3 months of visit (n=446) | ||||
| >400 copies/ml | 2.5 (1.5 to 4.2) | 0.01 | 1.7 (0.8 to 3.4) | 0.15 |
| ≤400 copies/ml | Reference | Reference | ||
| Reason for visit (n=440) | ||||
| STI screening | 0.2 (0.1 to 0.4) | 0.01 | 0.4 (0.2 to 0.8) | 0.01 |
| Other† | Reference | Reference | ||
*Missing data excluded in calculation of p values. N=287 for adjusted OR model.
†Includes symptomatic (n=52), positive STI test (n=1), contact to STI (n=1) or other (n=2).
HAART, highly active antiretroviral therapy; STI, sexually transmitted infection.